Company profile
Drug Discovery CNS/Oncology | ADMET, Pharmacokinetics | Pharmidex
Pharmidex provides translational solutions using its world renowned expertise in CNS/oncology, drug discovery and ADMET/PK.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNzAzODc0OWFkaXF6a2N4
Published 24 Sep 2024 05:06
Company registered at Companies House
